BCTX
Briacell Therapeutics CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$26.71M
P/E Ratio
—
EPS
$-14.42
Beta
1.64
52W High
$34.70
52W Low
$2.88
50-Day MA
$3.92
200-Day MA
$6.92
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Briacell Therapeutics Corp
BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-30.63M |
| Operating Margin | 0.00% |
| Return on Equity | -179.20% |
| Return on Assets | -89.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.26 |
| Price-to-Book | 0.86 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -1.38 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $8.70M |
| Float | $6.55M |
| % Insiders | 0.51% |
| % Institutions | 5.33% |
Historical Volatility
HV 10-Day
58.04%
HV 20-Day
132.22%
HV 30-Day
109.30%
HV 60-Day
91.55%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/11/2026